Retrospective analysis of fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide.

被引：1
|
作者：
Sridhar, Srikala S.
Smith, Alan D.
Fallah-Rad, Nazanin
Hansen, Aaron Richard
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.374
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Frailty and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.
    Deol, Ekamjit Singh
    Luo, Suhong
    Sanfilippo, Kristen Marie
    Eisen, Seth A.
    Schoen, Martin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [2] Natural killer cell activity in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.
    Zedan, Ahmed
    Nederby, Line
    Volmer, Lone
    Madsen, Christine Vestergaard
    Sorensen, Bente E.
    Hansen, Torben
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [3] Biomarker Analysis of Men With Enzalutamide-Resistant Metastatic Castration-Resistant Prostate Cancer Treated With Pembrolizumab
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (11) : 15 - 16
  • [4] Statin use and survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate or enzalutamide.
    Buonerba, Carlo
    Sonpavde, Guru
    Pond, Gregory Russell
    Pagliuca, Martina
    Rossetti, Sabrina
    Facchini, Gaetano
    Scagliarini, Sarah
    Daniele, Bruno
    Federico, Piera
    Morelli, Franco
    Carteni, Giacomo
    Ferro, Matteo
    Lucarelli, Giuseppe
    Bellelli, Teresa
    De Placido, Sabino
    di Lorenzo, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Fatigue in men with metastatic castration-resistant prostate cancer treated with enzalutamide: data from randomised clinical trials
    Chowdhury, S.
    Shore, N.
    Saad, F.
    Higano, C. S.
    Fizazi, K.
    Iversen, P.
    Miller, K.
    Heidenreich, A.
    Ueda, T.
    Kim, C. S.
    Phung, D.
    Krivoshik, A.
    Wang, F.
    Wu, K.
    Tombal, B.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] FATIGUE IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER TREATED WITH ENZALUTAMIDE: DATA FROM RANDOMIZED CLINICAL TRIALS
    Azad, Arun
    Saad, Fred
    Chowdhury, Simon
    Shore, Neal
    Higano, Celestia
    Fizazi, Karim
    Iversen, Peter
    Miller, Kurt
    Heidenreich, Axel
    Kim, Choung Soo
    Phung, De
    Krivoshik, Andrew
    Wang, Fong
    Tombal, Bertrand
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 41 - 41
  • [7] Biomarkers for early prognostication of outcome in patients with bone-metastatic castration-resistant prostate cancer treated with enzalutamide.
    Schlack, Katrin
    Boegemann, Martin
    Krabbe, Laura-Maria
    Kannen, Karoline
    Semjonow, Axel
    Klaile, Yvonne
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] Safety and effectiveness of enzalutamide in men with metastatic, castration-resistant prostate cancer
    Graff, Julie N.
    Gordon, Max J.
    Beer, Tomasz M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (05) : 749 - 754
  • [9] Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study
    Maughan, Benjamin L.
    Luber, Brandon
    Nadal, Rosa
    Antonarakis, Emmanuel S.
    PROSTATE, 2017, 77 (01): : 33 - 40
  • [10] Comparing sequencing of abiraterone and enzalutamide in men with metastatic castration-resistant prostate cancer: A retrospective study
    Azuma, Takeshi
    PROSTATE, 2018, 78 (04): : 278 - 278
12345